146 related articles for article (PubMed ID: 27162762)
21. Prevalence of Hepatitis B and C among Drug-Abusing Male Prisoners in Birjand, South Khorasan, Iran.
Ghafari S; Sharifzadeh G; Jamali S; Taji B; Javadmoosavi SY; Ziaee M
Arch Iran Med; 2019 Sep; 22(9):501-504. PubMed ID: 31679371
[TBL] [Abstract][Full Text] [Related]
22. Viral hepatitis and HIV infection among injection drug users in a central Iranian City.
Sofian M; Aghakhani A; Banifazl M; Azadmanesh K; Farazi AA; McFarland W; Eslamifar A; Ramezani A
J Addict Med; 2012 Dec; 6(4):292-6. PubMed ID: 22895463
[TBL] [Abstract][Full Text] [Related]
23. Low prevalence of hepatitis B and C among tuberculosis patients in Duhok Province, Kurdistan: Are HBsAg and anti-HCV prerequisite screening parameters in tuberculosis control program?
Merza MA; Haji SM; Alsharafani AM; Muhammed SU
Int J Mycobacteriol; 2016 Sep; 5(3):313-317. PubMed ID: 27847016
[TBL] [Abstract][Full Text] [Related]
24. Community-based sero-prevalence of hepatitis B and C infections in South Omo Zone, Southern Ethiopia.
Woldegiorgis AE; Erku W; Medhin G; Berhe N; Legesse M
PLoS One; 2019; 14(12):e0226890. PubMed ID: 31887192
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of antibodies to human immunodeficiency virus (HIV), hepatitis B and hepatitis C and risk factors in prisoners in Lebanon.
Mahfoud Z; Kassak K; Kreidieh K; Shamra S; Ramia S
J Infect Dev Ctries; 2010 Mar; 4(3):144-9. PubMed ID: 20351454
[TBL] [Abstract][Full Text] [Related]
26. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
Amini S; Mahmoodi MF; Andalibi S; Solati AA
J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of markers of hepatotropic viruses among drug addicts in Warsaw, Poland.
Laskus T; Radkowski M; Lupa E; Slusarczyk J; Cianciara J; Halama G; Nowicka R
J Hepatol; 1992 May; 15(1-2):114-7. PubMed ID: 1324268
[TBL] [Abstract][Full Text] [Related]
28. HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India.
Ray Saraswati L; Sarna A; Sebastian MP; Sharma V; Madan I; Thior I; Pulerwitz J; Tun W
BMC Public Health; 2015 Jul; 15():726. PubMed ID: 26223866
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of blood-borne viruses among Iranian dentists: Results of a national survey.
Ahmad Akhoundi MS; Momeni N; Norouzi M; Ghalichi L; Shamshiri AR; Alavian SM; Poortahmasebi V; Jazayeri SM
Int J Occup Med Environ Health; 2015; 28(3):593-602. PubMed ID: 26190734
[TBL] [Abstract][Full Text] [Related]
30. Sexually Transmitted Infections Among Hospitalized Patients With Human Immunodeficiency Virus Infection and Acquired Immune Deficiency Syndrome (HIV/AIDS) in Zahedan, Southeastern Iran.
Hashemi-Shahri SM; Sharifi-Mood B; Kouhpayeh HR; Moazen J; Farrokhian M; Salehi M
Int J High Risk Behav Addict; 2016 Sep; 5(3):e28028. PubMed ID: 27818966
[TBL] [Abstract][Full Text] [Related]
31. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.
Crofts N; Hopper JL; Milner R; Breschkin AM; Bowden DS; Locarnini SA
Eur J Epidemiol; 1994 Dec; 10(6):687-94. PubMed ID: 7672048
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and correlates of co-infection with human immunodeficiency virus and hepatitis C virus in male injection drug users in Iran.
Hosseini M; SeyedAlinaghi S; Kheirandish P; Esmaeli Javid G; Shirzad H; Karami N; Jahani M; Seyed Ahmadian M; Payvarmehr F; Mohraz M; Emadi Koochak H; McFarland W
Arch Iran Med; 2010 Jul; 13(4):318-23. PubMed ID: 20597566
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
Badridze N; Chkhartishvili N; Abutidze A; Gatserelia L; Sharvadze L
Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
[TBL] [Abstract][Full Text] [Related]
34. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
Butler T; Boonwaat L; Hailstone S; Falconer T; Lems P; Ginley T; Read V; Smith N; Levy M; Dore G; Kaldor J
Aust N Z J Public Health; 2007 Feb; 31(1):44-50. PubMed ID: 17333608
[TBL] [Abstract][Full Text] [Related]
35. [Attitudes of medical specialists toward HBV, HCV or HIV infected surgical staff and a sero-survey among staff members].
Gańczak M; Szych Z; Szczeniowski A; Dmytrzyk-Danilów G
Med Pr; 2013; 64(5):639-47. PubMed ID: 24502127
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
[TBL] [Abstract][Full Text] [Related]
37. Epidemiological profile and risk factors of HIV and HBV/HCV co-infection in Fujian Province, southeastern China.
Wu S; Yan P; Yang T; Wang Z; Yan Y
J Med Virol; 2017 Mar; 89(3):443-449. PubMed ID: 27552721
[TBL] [Abstract][Full Text] [Related]
38. Bloodborne virus infections among drug users in Ireland: a retrospective cross-sectional survey of screening, prevalence, incidence and hepatitis B immunisation uptake.
Grogan L; Tiernan M; Geogeghan N; Smyth B; Keenan E
Ir J Med Sci; 2005; 174(2):14-20. PubMed ID: 16094907
[TBL] [Abstract][Full Text] [Related]
39. [Viral infections in intravenous drug addicts. Clinical and prognostic significance].
Glória H; Ramalho F; Marinho R; Pedro M; Velosa J; Moura MC
Acta Med Port; 1991; 4(5):263-7. PubMed ID: 1785366
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
